Retracted: Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients (Movement Disorders, (2005), 20, 12, (1598-1603), 10.1002/mds.20658);Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients

Movement Disorders

Volumn 20, Issue 12, 2005, Pages 1598-1603

  Sato, Yoshihiro ^a   Honda, Yoshiaki ^a   Iwamoto, Jun ^b   Kanoko, Tomohiro ^c   Satoh, Kei ^c  

^a Mitate Hospital   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

Bone mineral density; Hypercalcemia; Immobilization; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; CALCIUM ION; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE;

ABNORMAL URINE COMPOSITION; AGED; ARTICLE; BLOOD CHEMISTRY; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROLYTE DISTURBANCE; FEMALE; HORMONE RELEASE; HUMAN; HYPERCALCEMIA; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; METACARPAL BONE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; UNIFIED PARKINSON DISEASE RATING SCALE III; URINE LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL;

AGED; ANALYSIS OF VARIANCE; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMOBILIZATION; LINEAR MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; VITAMIN D;

EID: 33644941594     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.27592     Document Type: Erratum

References (38)

1. Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 2003;212:47-53.
2. Grimbergen YA, Munneke M, Bloem BR. Falls in Parkinson's disease. Curr Opin Neurol 2004;17:405-415.
3. Bloem BR, Hausdorff JM, Visser JE, Giladi N. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord 2004;19:871-884.
4. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991;324:1326-1331.
5. Eventov I, Moreno M, Geller E, Tardiman R, Salama R. Hip fractures in patients with Parkinson's syndrome. J Trauma 1983; 23:98-101.
6. Chantraine A, Nusgens B, Lapiere CM. Bone remodeling during the development of osteoporosis in paraplegia. Calcif Tissue Int 1986;38:323-327.
7. Biering-Sørensen F, Bohr HH, Schaadt OP. Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury. Eur J Clin Invest 1990; 20:330-335.
8. Clouston WM, Lloyd HM. Immobilization-induced hypercalcemia and regional osteoporosis. Clin Orthop Rel Res 1987;216:247-252.
9. Minaire P, Meunier P, Edouard C, Bernard J, Courpron P, Bourret J. Quantitative histological data on disuse osteoporosis: comparison with biological data. Calcif Tissue Res 1974;17:57-73.
10. Sato Y, Fujimatsu Y, Kikuyama M, Kaji M, Oizumi K. Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke. J Neurol Sci 1998;156:205-210.
11. Ishizaki F, Harada T, Katayama S, Abe H, Nakamura S. Relationships between osteopenia and clinical characteristics of Parkinson's disease. Mov Disord 1993;8:507-511.
12. Kao CH, Chen CC, Wang SJ, Chia LG, Yeh SH. Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometry. Nucl Med Commun 1994;15:173-177.
13. Taggart H, Crawford V. Reduced bone density of the hip in elderly patients with Parkinson's disease. Age Ageing 1995;24: 326-328.
14. Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 1997;49:1273-1278.
15. Sato Y, Kaji M, Kuno H, Tsuru T, Satoh K, Kondo I. Vitamin K deficiency and osteopenia in vitamin D-deficient elderly female patients with Parkinson's disease. Arch Phys Med Rehabil 2002; 83:86-91.
16. Sato Y, Honda Y, Kaji M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 2002;31:114-118.
17. Ganong WF. Hormonal control of calcium metabolism and the physiology of bone. In: Ganong WF, editor. Review of medical physiology, 21st ed. New York: McGraw-Hill, 2003. p 385-398.
18. Garnero P, Grimaux M, Seguin P, Delmas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9:255-264.
19. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;2:142-146.
20. Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004;19:1221-1230.
21. Robins SP, Black D, Petersen CR. Evaluation of urinary hydroxypyridinium cross-link measurements as resorption markers in metabolic bone disease. Eur J Clin Invest 1991;21:310-315.
22. Matsumoto C, Kushida K, Yamazaki K, Imose K, Inoue T. Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry. Calcif Tissue Int 1994;55: 324-329.
23. Fahn S, Elton R, Members of UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease, vol. 2. New York: Macmillan; 1987. p 153-163.
24. Komar L, Nieves J, Cosman F, Rubin A, Shen V, Lindsay R. Calcium homeostasis of an elderly population upon admission to a nursing home. J Am Geriatr Soc 1993;41:1057-1064.
25. Beadle PC. Sunlight, ozone and vitamin D. Br J Dermatol 1997; 97:585-591.
26. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994;44:1687-1692.
27. Gloth FM, Gundberg CM, Hollis BW, Haddad JG, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995; 274:1683-1686.
28. 2 D. Am J Clin Nutr 1990;52;701-706.
29. Sato Y, Kaji M, Tsuru T, Oizumi K. Risk factors for hip fracture among elderly patients with Parkinson's disease. J Neurol Sci 2001;82:89-93.
30. Villareal DT, Civitelli R, Chines A, Avioli LV. Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab 1991;72:628-634.
31. Sato Y, Honda Y, Asoh T, Kikuyama M, Oizumi K. Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis. Eur Neurol 1997;37:225-229.
32. Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 1982;306:1136-1140.
33. Henke JA, Thompson NW, Kaufer H. Immobilization hypercalcemic crisis. Arch Surg 1975;110:321-323.
34. Sato Y, Manabe S, Kuno H, Oizumi K. Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;66:64-68.
35. Derisquebourg T, Dubois P, Devogelaer JP, et al. Automated computerized radiogrammetry of the second metacarpal and its correlation with absorptiometry of the forearm and spine. Calcif Tissue Int 1994;54:461-465.
36. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337: 670-676.
37. Tilyard MW, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;336:357-362.
38. McClung MR, Geusens P, Miller PD, et al. Hip intervention program study group: effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-340.